Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dynavax and Stallergenes to develop seasonal allergy therapy

Nov. 29, 1999

Amrad to distribute PathoGenesis's inhalable CF treatment in Australia

Nov. 26, 1999

SB investigates CCR3 receptor blockade as a novel approach to allergic, inflammatory disorders

Nov. 25, 1999

Advair approved in Canada, recommended for approval in U.S.

Nov. 25, 1999

Curosurf approved in U.S. for treatment of RDS in premature infants

Nov. 25, 1999

Sepracor and Abbott to copromote Xopenex in the U.S.

Nov. 22, 1999

Dual NK1/NK2 antagonist examined for disposition in rats

Nov. 22, 1999

RPR's new cell adhesion inhibitors especially useful for asthma, joint inflammation and IBD

Nov. 22, 1999

Potent, selective and stable tryptase inhibitors developed at Protherics

Nov. 22, 1999

Fournier's new bradykinin antagonists particularly useful for asthma, rhinitis

Nov. 16, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026